Ignite Creation Date:
2024-05-06 @ 5:42 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05406778
Status:
RECRUITING
Last Update Posted:
2022-07-08
First Post:
2022-05-26
Brief Title:
SPARK Neuro REMIND Study
Sponsor:
Spark Neuro Inc
Organization:
Spark Neuro Inc
Study Overview
Official Title:
SPARK Neuro Quantitative Resting State EEG Protocol for Assessing Cognitive Impairment and AD Status REMIND Study
Status:
RECRUITING
Status Verified Date:
2022-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study utilizes investigational software the SPARK Test with an FDA-cleared electroencephalography EEG amplifier and EEG cap to collect and then analyze patient EEG data
Detailed Description:
The aim of this study is to develop an algorithm and then evaluate it to determine whether applying machine-learning techniques to resting-state electroencephalography EEG can characterize patients cognitive status and detect the presence or absence of AD on the basis of the patients EEG
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
True
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None